# DESCRIPTION

## FIELD OF THE INVENTION

## BACKGROUND INFORMATION

## BRIEF DESCRIPTION OF THE DRAWINGS

## DETAILED DESCRIPTION

### Materials and Methods

## Results

### Functional Expression of Human CXCR4 in Yeast.

### Library Screening and Agonist Isolation.

### CXCR4 Dependence of RSVM and ASLW Effect.

### Peptide Assays.

### Effect of AMD3100, T140, 12G5, and 44717.111.

### Full-Length Mutants.

### Flow Cytometry.

## Discussion

### CXCR4 Activation.

### Allosteric CXCR4 Agonists.

### Drug Development.

### Therapeutic Implications.

## Acknowledgements

